Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM4PT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,988
Award facts
- Contract value 100% obligated
- $51,987.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for Reblozyl 75 mg vials with a ceiling value of $51,987.66.
Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 11, 2026, and is priced on a firm fixed-price basis. The delivery order was issued without a set-aside.
Quick answers
Who was awarded contract SPE2DR26FM4PT?
SPE2DR26FM4PT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 18, 2026.
How much is contract SPE2DR26FM4PT worth?
The government has obligated $51,988 on SPE2DR26FM4PT.
Is contract SPE2DR26FM4PT an order under another contract?
Yes. SPE2DR26FM4PT is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM4PT competed?
The extent of competition for SPE2DR26FM4PT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award